This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bush, L M Articles by Kaye, D Search for Related Content PubMed PubMed Citation Articles by Bush, L M Articles by Kaye, D

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1988 June; 32(6): 877-881

Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.

L M Bush, J A Boscia and D Kaye

Department of Medicine, Medical College of Pennsylvania, Philadelphia 19129.

ABSTRACT

This study compared daptomycin (LY146032) with penicillin G procaine and vancomycin without and with gentamicin for treatment of experimental enterococcal endocarditis. The strain of Streptococcus (Enterococcus) faecalis used in this study was killed by daptomycin in vitro in broth but not in serum. In rabbits treated for 3 days, daptomycin significantly reduced bacterial counts of vegetations compared with no therapy but was significantly less effective than penicillin G procaine or vancomycin. Daptomycin-gentamicin significantly reduced bacterial counts of vegetations compared with daptomycin alone but was significantly less effective than vancomycin plus gentamicin. The efficacy of daptomycin-gentamicin did not differ significantly from that of penicillin G procaine-gentamicin. The lack of enterococcal killing by daptomycin alone in serum and in experimental endocarditis is probably related to the high protein binding of the agent.

---

Antimicrob Agents Chemother. 1988 June; 32(6): 877-881

This article has been cited by other articles:

• Falagas, M. E., Giannopoulou, K. P., Ntziora, F., Vardakas, K. Z. (2007). Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J Antimicrob Chemother 60: 7-19 [Abstract] [Full Text]  
• Vouillamoz, J., Moreillon, P., Giddey, M., Entenza, J. M. (2006). Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. J Antimicrob Chemother 58: 1208-1214 [Abstract] [Full Text]  
• Shah, M., Murillo, J. L (2005). Successful Treatment of Corynebacterium striatum Endocarditis with Daptomycin plus Rifampin. The Annals of Pharmacotherapy 39: 1741-1743 [Abstract] [Full Text]  
• Rybak, M. J., Hershberger, E., Moldovan, T., Grucz, R. G. (2000). In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains. Antimicrob. Agents Chemother. 44: 1062-1066 [Abstract] [Full Text]  
• Wells, V. D., Wong, E. S., Murray, B. E., Coudron, P. E., Williams, D. S., Markowitz, S. M. (1992). Infections Due to Beta-Lactamase-producing, High-Level Gentamicin-resistant Enterococcus faecalis. ANN INTERN MED 116: 285-292 [Abstract]  
• Bush, L. M., Calmon, J., Cherney, C. L., Wendeler, M., Pitsakis, P., Poupard, J., Levison, M. E., Johnson, C. C. (1989). High-Level Penicillin Resistance among Isolates of Enterococci: Implications for Treatment of Enterococcal Infections. ANN INTERN MED 110: 515-520 [Abstract]